Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Kevin Bercimuelle-Chamot, Jocelyn Bosse, Alessandro Cerri, Anastasiia Kyrylenko, Marcel Pemsel and Anna Maria Stein.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Antonios Baris (Book Review Editor), Rose Hughes (PatKat) and Chijioke Okorie (Africa Correspondent).

InternKats: Asude Sena Moya and Söğüt Atilla.
Home / / INDIAN PATENT AMENDMENTS CRITICISED

INDIAN PATENT AMENDMENTS CRITICISED


At last, and delayed from Monday...RxPG News reports that NGO Medicin sans Frontiers has expressed concern at India’s recent amendments to its Patent Act. Previous India did not grant product patents, but this has changed in an attempt to make India TRIPs compliant. This will make it easier for pharmaceutical companies to obtain Indian patents. India has also made it harder to get compulsory licences granted on public health grounds. However, patented technology that is already the subject of a compulsory licence will continue to be available to the manufacturers of generics, but on payment of a licence fee. Currently 50% of those on anti-retroviral drugs rely on Indian generic versions.


The IPKat thinks that, if there’s a problem, the correct way isn’t to attack India for complying with its international obligations. Either it’s to call for TRIPs to be amended to better take into account the needs of those who cannot afford crucial treatment, or to continue to encourage the IP rights-holders to make those drugs available to those in serious need on preferential terms.
INDIAN PATENT AMENDMENTS CRITICISED INDIAN PATENT AMENDMENTS CRITICISED Reviewed by Anonymous on Wednesday, March 30, 2005 Rating: 5

1 comment:

  1. AnonymousThursday, 31 March 2005 at 12:00:00 GMT+1

    At least in part, the criticism asks whether India has made as much use as it could have done of the flexibilities which _are_ allowed under TRIPS, and the recent Doha agreement.

    But a question does remain, as to whether in practice these allowed flexibilities go far enough.

    ReplyDelete

All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.

It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.

Learn more here: http://ipkitten.blogspot.com/p/want-to-complain.html

Subscribe to: Post Comments ( Atom )
Powered by Blogger.